18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
Saxagliptin is a new investigational medication being developed for treatment of type 2
diabetes. This study is designed to assess the efficacy and tolerability of saxagliptin in
addition to metformin and compare to sitagliptin in addition with metformin.